---
schema_version: "secwatch.filing_event.v1"
accession: "0001553350-22-000721"
form_type: "8-K"
ticker: "PDEX"
cik: "0000788920"
company_name: "PRO DEX INC"
filed_at: "2022-08-25T23:59:59+00:00"
generated_at: "2026-06-23T21:32:26.321897+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Pro-Dex Q4 revenue up 34% to $12.6M; full-year net income $3.9M

## Summary
- Q4 net sales $12.6M (+34% YoY); net income $1.4M ($0.38/diluted) vs $0.8M ($0.20) in Q4 FY21.
- Full-year net sales $42.0M (+11% YoY); net income $3.9M ($1.02/diluted) vs $5.8M ($1.48) in FY21.
- Q4 gross margin fell to 27% from 33% due to component price increases outpacing pass-through.
- Largest customer orthopedic device sales rose $3.8M in FY22 on next-gen handpiece launch.
- CEO cites positive outlook with new building capacity; company does not provide guidance.

## SEC filing metadata
- accession: 0001553350-22-000721
- form_type: 8-K
- ticker: PDEX
- cik: 0000788920
- company_name: PRO DEX INC
- filed_at: 2022-08-25T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/788920/000155335022000721/0001553350-22-000721-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/788920/000155335022000721/pdex_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001553350-22-000721
- JSON: https://secwatch.observer/filing/0001553350-22-000721.json
- Plain text: https://secwatch.observer/filing/0001553350-22-000721.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.